FDA Affirms Risks of Abortion Drug Mifepristone

Three Additional Weeks Allowed for Chemical Abortions


DATE: Wednesday, March 30, 2016     PHONE: 614-547-0099 ext. 304

The following statement is in response to the Food and Drug Administration's new label for the abortion drug mifepristone. It should be attributed to Katie Franklin, director of communications for Ohio Right to Life.

"The FDA has essentially affirmed the pro-life position as it relates to the serious risks of taking mifepristone. The fact is that this drug causes severe and negative harm to women, including very heavy bleeding, nausea, weakness, fever, chills, vomiting, as well as serious and sometimes fatal infections and bleeding. In Ohio, we have a number of reported cases of botched chemical abortions logged with the State Medical Board. Nationwide, over 2,000 adverse effects have been reported to the FDA. The tragedy is that the FDA just allowed three additional weeks for women and their babies to be placed in harm's way."


Founded in 1967, Ohio Right to Life, with more than 45 chapters and local affiliates, is Ohio's oldest and largest grassroots pro-life organization. Recognized as the flagship of the pro-life movement in Ohio, ORTL works through legislation and education to promote and defend innocent human life from conception to natural death.


Be the first to comment

Please check your e-mail for a link to activate your account.


Sign Up

Vote Pro-Life

The Guide

Save A Life


Unborn Child Dignity Act

S.B. 254 & H.B. 417/419